Legal status in Guyana

Per-substance legal status for Guyana, from sourced statutes where available. Legal information, not legal advice; drug laws change, so confirm with the destination’s embassy or drug authority before you travel.

36 confirmed substances52 not individually verifiedLast updated October 9, 2026

Confirmed legal status

Adderall

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «anfetamina; dextroanfetamina», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. Adderall is a brand, and a brand word is not a schedule entry. The row is resolved only through the two active amphetamine ingredients the dossier names, and it is those names rather than the trade name that the schedule prints. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «anfetamina; dextroanfetamina» itself. A charge would be built on the mixed amphetamine salts in the tablet, so the active ingredient declared on the dispensing label is what matters and not the brand printed on the box. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «anfetamina; dextroanfetamina» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. This is a prescribed medicine in many countries and the dossier still carries no Guyanese import or personal medicine route for it, which is exactly the gap a traveller on a stimulant prescription needs closed. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: A prescription naming the brand alone is the weakest form of this document, because the schedule does not print the brand. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «anfetamina; dextroanfetamina».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «anfetamina · dextroanfetamina» and the row boundary the dossier records for that read is «resolves a branded mixed-salt medicine only through its two active amphetamine ingredients.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «adderall schedule | adderall penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Adderall in Guyana, full detail →

Alcohol

Legal status: Not assigned a controlled drug offence in Guyana. The scope search recorded for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «alcohol; etanol», and the dossier records the result as a scope finding: this substance is not placed in those Schedules and the Act's trafficking offence does not reach it. Beverage alcohol and ethanol are regulated as a product, through licensing and excise, and reserving that regulation is not the same as saying it is light. That is a finding about this Act and about nothing else. Separate product, excise, tobacco, food and medicines law is expressly reserved, and the dossier does not describe it. The scope search was recorded on 20 September 2026.
Consequences if caught: Capital exposure: none for this row. The only capital provision in Guyana's Cap. 10:10, section 6(1), applies to supplying or administering a narcotic to a child or young person who dies as a result, and this row is not a narcotic under the Act, so the trafficking penalties of section 5(1), which reach imprisonment for life on indictment, do not apply to it either. This row does not reach even that, because no criminal controlled drug ceiling is assigned to it at all. Drink driving, licensing and duty enforcement are all real exposures and none of them sits in this Act. The consequence is not that the substance is unregulated. It is that the regulation, whatever it amounts to, sits outside the criminal drug statute the dossier read, in law the dossier did not examine.
If prescribed / medical: Not a controlled drug question in Guyana, so there is no schedule placement for a prescription to be measured against. Ethanol appears in medicines as an excipient rather than as an active ingredient, which is a different question again. The dossier carries no Guyanese prescription rule, import permit or personal allowance in any event, so nothing here should be read as a customs or duty allowance.
Documentation: There is no narcotics schedule paperwork to carry for alcohol. The scope finding recorded for this row was read on 20 September 2026 against «alcohol; etanol». Because the reserved law was never examined, the honest position is that this cell tells you what the drug statute does not do and not what any other statute does.

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, read for this row as a scope finding rather than a placement · the term searched is «alcohol · etanol» and the row boundary the dossier records for that search is «reserves beverage and ethanol controls instead of assigning a narcotics-list offence.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «alcohol schedule | alcohol penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Alcohol in Guyana, full detail →

Amphetamine

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «anfetamina», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The substance searched for is the base stimulant. Salts and stereochemical forms are covered only so far as the printed entry itself reaches them, and the dossier records no separate isomer limb for this row. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «anfetamina» itself. A powder has to be identified as amphetamine rather than as a substituted analogue, because the neighbouring cathinone and benzofuran rows in this corpus do not resolve the same way. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «anfetamina» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Amphetamine appears in licensed medicines as well as in illicit powder, and the dossier settles which schedule it sits in without settling how a patient may lawfully bring it in. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: The active ingredient, not the presentation, is what the schedule is read against. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «anfetamina».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «anfetamina» and the row boundary the dossier records for that read is «uses the base stimulant entry together with salts and stereochemical forms only where covered.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «amphetamine schedule | amphetamine penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Amphetamine in Guyana, full detail →

Ayahuasca

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «dimetiltriptamina (DMT)», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. Ayahuasca is a brew rather than a molecule, and it is resolved here through its identified dimethyltryptamine content. The entry reached is the tryptamine, so the plant material and the preparation question are left standing rather than answered. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «dimetiltriptamina (DMT)» itself. A brew has to be shown to contain the scheduled tryptamine before section 5(1) is in play, and the dossier records no ceremonial or religious exemption in Guyana. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «dimetiltriptamina (DMT)» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Ayahuasca is not a dispensed medicine, so the question is not a prescription but whether any authorisation exists for the tryptamine content, and the dossier records none. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: No traveller document converts a tryptamine bearing brew into a lawful import, and a letter from a retreat or a church is not an authorisation under this Act. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «dimetiltriptamina (DMT)».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «dimetiltriptamina (DMT)» and the row boundary the dossier records for that read is «resolves a plant preparation through identified DMT while preserving the preparation issue.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «ayahuasca schedule | ayahuasca penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Ayahuasca in Guyana, full detail →

Barbiturates

Legal status: Controlled, and the applied cell has this the wrong way round. It says a member search naming phenobarbital, secobarbital, amobarbital and butalbital returned no proved current named entry for any of the four. Three of the four are named in the Act. Part III of the Second Schedule prints «AMOBARBITAL» at 5-ethyl-5-(3-methylbutyl) barbituric acid, «SECOBARBITAL» at 5-allyl-5-(1-methylbutyl) barbituric acid, and also «CYCLOBARBITAL», «GLUTETHIMIDE» and «PENTOBARBITAL». Phenobarbital appears in the consolidation as well. Only butalbital is absent. Read off the page image of page 123 at 170 dpi and confirmed in the text layer [Certain]. So a barbiturate in this corpus is placed unless it is butalbital, and the class does not fail for want of a member. The version horizon, stated outright because an absence without one expires silently and says nothing about having expired: the list read is the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 as it stands at L.R.O. 1/2012, and the Minister may amend the Schedules by order, so this does not rule out a later addition.
Consequences if caught: Capital exposure: one narrow route, and only where the material is a barbiturate the Second Schedule prints: «AMOBARBITAL», «CYCLOBARBITAL», «PENTOBARBITAL» and «SECOBARBITAL» at Part III, and «BARBITAL», «METHYL-PHENOBARBITAL» and «PHENOBARBITAL» at Part IV. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing. Butalbital is not printed.
If prescribed / medical: Deferred twice over, and both halves are honest. The dossier carries no Guyanese prescription rule, import permit or personal medicine allowance of any kind, and it also settles no placement for any barbiturate, so neither part of the question can be answered. Phenobarbital is the practical case, because a patient carrying it for epilepsy is carrying a medicine whose status here is unproved rather than cleared. Identify the compound first, then settle it with the Guyanese authorities before travelling.
Documentation: Have the prescription name the barbiturate, because the class word is precisely the thing that cannot be answered. Carry the medicine in its original dispensing packaging with a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period. Nothing in the dossier confirms that Guyana accepts any of it. The member search recorded for this row was read on 20 September 2026 and named four barbiturates, none of them proved as a current entry.

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, searched member by member for this row without a proved result · the members recorded are «phenobarbital, secobarbital, amobarbital and butalbital» and the row boundary the dossier records is «requires an identified member because the corpus contains no individual barbiturate row.», a ground stated about this corpus rather than about the Guyanese schedule · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «barbiturates schedule | barbiturates penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Barbiturates in Guyana, full detail →

Buprenorphine

Legal status: Controlled, and the applied cell reaches the right answer by a route it never states. The string buprenorphine does not appear anywhere in the consolidation [Certain]. What the Act does print, in the First Schedule, is a list closing «(4) Narcotine (5) Papaverine (6) Thebaine, and their preparations, derivatives and salts». Buprenorphine is a semi-synthetic derivative of thebaine, so the derivatives limb of that entry is the route, and the entry the cell should cite is «Thebaine» and not a Spanish search term. Oripavine also appears, inside the chemical name printed against «Etorphine». This is a reading of the derivatives limb and not a printed entry for buprenorphine, and the cell says so rather than passing it off as one. Whether a court would read derivatives that widely is not settled here. The version horizon, stated outright because an absence without one expires silently and says nothing about having expired: the list read is the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 as it stands at L.R.O. 1/2012, and the Minister may amend the Schedules by order, so this does not rule out a later addition.
Consequences if caught: Capital exposure: none. Guyana's Cap. 10:10 carries no death penalty at any tier; section 5(1) sets the indictable trafficking ceiling at life imprisonment, so the worst outcome this Act reaches is a life sentence. No per-substance number is printed for this row, so the schedule supplies the placement and section 5(1) supplies the ceiling: there is no weight band, no tariff and no quantity threshold attached to «buprenorfina» itself. Opioid substitution material is identified by its active ingredient, so a film or a tablet has to be shown to contain buprenorphine rather than another maintenance drug. What the ceiling does not do is say where inside it a case lands, and the dossier records no sentencing range, no minimum and no fine figure for this row.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «buprenorfina» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Buprenorphine is most often carried as opioid substitution treatment, which is precisely the case where an import permit route would matter, and the dossier records no such route for Guyana. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: A treatment programme letter is worth carrying alongside the prescription, although nothing in the dossier says Guyana accepts one. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «buprenorfina».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «buprenorfina» and the row boundary the dossier records for that read is «checks the semisynthetic opioid entry rather than treating every opioid medicine alike.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «buprenorphine schedule | buprenorphine penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 2, 2026

Buprenorphine in Guyana, full detail →

Caffeine

Legal status: Not assigned a controlled drug offence in Guyana. The scope search recorded for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «cafeína», and the dossier records the result as a scope finding: this substance is not placed in those Schedules and the Act's trafficking offence does not reach it. Caffeine is regulated as a food ingredient and as a medicine constituent, both of which sit outside the criminal drug schedule. That is a finding about this Act and about nothing else. Separate product, excise, tobacco, food and medicines law is expressly reserved, and the dossier does not describe it. The scope search was recorded on 20 September 2026.
Consequences if caught: Capital exposure: none for this row. The only capital provision in Guyana's Cap. 10:10, section 6(1), applies to supplying or administering a narcotic to a child or young person who dies as a result, and this row is not a narcotic under the Act, so the trafficking penalties of section 5(1), which reach imprisonment for life on indictment, do not apply to it either. This row does not reach even that, because no criminal controlled drug ceiling is assigned to it at all. High dose caffeine powders have caused deaths and are restricted in some countries under food safety law, which is exactly the reserved category here. The consequence is not that the substance is unregulated. It is that the regulation, whatever it amounts to, sits outside the criminal drug statute the dossier read, in law the dossier did not examine.
If prescribed / medical: Not a controlled drug question in Guyana, so there is no schedule placement for a prescription to be measured against. Caffeine appears in over the counter analgesics and in stimulant tablets, and the dossier describes how Guyana regulates neither. The dossier carries no Guyanese prescription rule, import permit or personal allowance in any event, so nothing here should be read as a customs or duty allowance.
Documentation: No narcotics documentation applies to caffeine. The scope finding recorded for this row was read on 20 September 2026 against «cafeína». Because the reserved law was never examined, the honest position is that this cell tells you what the drug statute does not do and not what any other statute does.

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, read for this row as a scope finding rather than a placement · the term searched is «cafeína» and the row boundary the dossier records for that search is «reserves food and medicine regulation outside the criminal controlled-drug schedule.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «caffeine schedule | caffeine penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Caffeine in Guyana, full detail →

Cannabinol

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «cannabinol», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. Cannabinol has its own printed entry. It is a minor natural cannabinoid and the entry is read separately from tetrahydrocannabinol and from cannabis plant material, so a cannabinol product does not answer to the cannabis row or to the cannabidiol row. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «cannabinol» itself. A product has to be shown to contain cannabinol itself, since cannabinoid content is routinely mixed and the neighbouring cannabinoid rows in this corpus do not resolve alike. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «cannabinol» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Cannabinol products are sold as supplements rather than dispensed as medicines, so an authorisation under the Act would be the only lawful route and none is recorded. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: A certificate of analysis showing the cannabinoid profile is the document that speaks to this entry. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «cannabinol».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «cannabinol» and the row boundary the dossier records for that read is «separates a minor natural cannabinoid from THC and from cannabis plant material.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «cannabinol schedule | cannabinol penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Cannabinol in Guyana, full detail →

Cannabis / THC

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «cannabis; resina DE cannabis; tetrahidrocannabinol», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The entry covers three things at once: the plant, the resin and the statutory tetrahydrocannabinol wording. They are read as printed and are not collapsed into cannabidiol, which this corpus checks on its own row and which the dossier does not prove as a named entry. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: none. Guyana's Cap. 10:10 carries no death penalty at any tier; section 5(1) sets the indictable trafficking ceiling at life imprisonment, so the worst outcome this Act reaches is a life sentence. This row also carries the one quantity rule the dossier records anywhere in Guyana: possession of 30 g or less of cannabis has no imprisonment under the 2022 amendment. Above that line the ordinary route returns and the section 5(1) trafficking ceiling is life. The dossier gives the 30 g figure and the 2022 amendment and nothing further, so no counselling scheme, community service band, fine figure or intermediate tier is asserted here, and the live cell's figures for those tiers are not carried forward. Identification still runs to the printed entry: the plant, the resin and the statutory tetrahydrocannabinol wording are three separate things, so the 30 g rule is a rule about cannabis in possession and does not transfer of its own force to a resin or to a concentrate. [Likely] Carried forward from the published entry and not re-derived from statute in this pass: Cannabis is controlled in Guyana under the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap 10:10, but the 2021 amendment removed custodial sentences for small quantities. In Guyana, drugs fall under the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap 10:10 (Act No. 2 of 1988, as amended through 2021). Possession (s.4) carries a fine of not less than G$30,000 or three times the market value of the narcotic, together with imprisonment of 3-5 years. Trafficking (s.5) is punished more heavily; the exact statutory maximum for trafficking is not pinned in the cited source and is not assumed here, verify the s.5 penalty. A 2021 reform, the Narcotic Drugs and Psychotropic Substances (Control) (Amendment) Act No. 2 of 2021, in force 2022, removed custodial sentences for small cannabis quantities: possession of up to 15 g of cannabis now draws mandatory counselling, and up to 30 g draws community service of up to 6 months, rather than imprisonment. Larger amounts and all trafficking remain criminal.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «cannabis; resina DE cannabis; tetrahidrocannabinol» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Cannabis is dispensed as a medicine in some countries and the dossier records no Guyanese medical cannabis route at all, so the 30 g possession rule is not a medical permission and must not be read as one. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: The 30 g line is about quantity in possession and not about paperwork, so no document enlarges it. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «cannabis; resina DE cannabis; tetrahidrocannabinol».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «cannabis · resina DE cannabis · tetrahidrocannabinol» and the row boundary the dossier records for that read is «checks plant, resin and statutory THC wording without collapsing them into CBD.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «cannabis schedule | cannabis penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. The finding in this cell is carried forward from the entry published before this batch and was not re-derived from statute in this pass · it is tagged [Likely] where it appears. · Updated September 21, 2026

Cannabis / THC in Guyana, full detail →

Cocaine

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «cocaína», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The substance searched for is cocaine. Coca leaf, the salts and finished preparations are kept analytically distinct from it, so a result for one is not automatically a result for the others. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band or tariff attached to «cocaína» itself. Section 5(2) prints a presumption: in a prosecution under section 5, a person found in possession of more than one gram of cocaine bears the burden of proving a purpose other than trafficking. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «cocaína» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Cocaine hydrochloride has a narrow topical anaesthetic use, and nothing in the dossier describes how that use is authorised in Guyana. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: No ordinary traveller documentation reaches this substance, and a foreign medical licence for topical cocaine is not a Guyanese authorisation. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «cocaína».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «cocaína» and the row boundary the dossier records for that read is «uses the cocaine entry and keeps coca leaf, salts and preparations analytically distinct.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «cocaine schedule | cocaine penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Cocaine in Guyana, full detail →

Codeine

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «codeína», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The substance searched for is the named opiate. Preparation and concentration exceptions are a real feature of codeine control in most systems, and the dossier does not record whether Cap. 10:10 prints one, so the low dose compound analgesic question is open rather than answered. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: none. Guyana's Cap. 10:10 carries no death penalty at any tier; section 5(1) sets the indictable trafficking ceiling at life imprisonment, so the worst outcome this Act reaches is a life sentence. No per-substance number is printed for this row, so the schedule supplies the placement and section 5(1) supplies the ceiling: there is no weight band, no tariff and no quantity threshold attached to «codeína» itself. A finished product has to be tied to the printed entry before the trafficking ceiling is in play, and the strength of the preparation may be the fact that decides it. What the ceiling does not do is say where inside it a case lands, and the dossier records no sentencing range, no minimum and no fine figure for this row.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «codeína» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Codeine is sold over the counter in some countries and dispensed on prescription in others, so the exemption question a traveller cares about is exactly the one the dossier leaves unresolved. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: Carry the pack that states the codeine strength per unit, because the strength is what any preparation exception would turn on. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «codeína».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «codeína» and the row boundary the dossier records for that read is «checks a named opiate while preserving applicable preparation and concentration exceptions.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «codeine schedule | codeine penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated September 21, 2026

Codeine in Guyana, full detail →

Crack Cocaine

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «cocaína», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. Crack is a dosage form and not a separate schedule entry. The dossier resolves it only after analytical identification as cocaine, so the placement is borrowed from the cocaine entry and the form itself adds nothing to the schedule. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band or tariff attached to «cocaína» itself. Section 5(2) prints a presumption: in a prosecution under section 5, a person found in possession of more than one gram of cocaine bears the burden of proving a purpose other than trafficking. The laboratory has to report cocaine; until it does, the street description of the material carries no statutory consequence at all. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «cocaína» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. There is no prescribing route for a smoked cocaine base, so the prescription question does not arise on this row. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: There is no documentation route for a smokable cocaine base, and the only record that will matter is the laboratory certificate. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «cocaína».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «cocaína» and the row boundary the dossier records for that read is «resolves the dosage form only after analytical identification as cocaine.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «crack-cocaine schedule | crack-cocaine penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Crack Cocaine in Guyana, full detail →

Delta-8-THC

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «delta-8-tetrahidrocannabinol», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The entry names the delta-8 positional isomer specifically. That is what makes this row separable from the generic cannabis entry and from delta-9 tetrahydrocannabinol, and a product sold as hemp derived does not escape a named isomer entry by being derived from hemp. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «delta-8-tetrahidrocannabinol» itself. Second Schedule Part I item 10 prints «Tetrahydrocannabinols, all isomers», so delta-8 and delta-9 are caught alike, and what has to be shown is that the material is a tetrahydrocannabinol. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «delta-8-tetrahidrocannabinol» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Delta-8 products are sold as consumer goods rather than dispensed, so a prescription is not the route and no authorisation is recorded. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: A certificate of analysis naming the isomer is the only document that speaks to this entry, and it is evidence of contents rather than permission to carry them. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «delta-8-tetrahidrocannabinol».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «delta-8-tetrahidrocannabinol» and the row boundary the dossier records for that read is «separates the delta-8 positional isomer from delta-9 THC and generic cannabis.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «delta-8-thc schedule | delta-8-thc penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Delta-8-THC in Guyana, full detail →

DMT

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «dimetiltriptamina (DMT)», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The substance searched for is the parent tryptamine. It is not extended to the acetoxy and methoxy analogues that carry their own rows in this corpus, and neither of those returned a proved entry. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «dimetiltriptamina (DMT)» itself. The material has to be identified as DMT or another tryptamine the Second Schedule prints, since an unlisted tryptamine is a different substance. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «dimetiltriptamina (DMT)» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Dimethyltryptamine is not dispensed, although it is under clinical investigation in several countries, and the dossier records no Guyanese research or authorisation route. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: No traveller document reaches synthesised dimethyltryptamine, and a preparation containing it is in no better position than the pure compound. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «dimetiltriptamina (DMT)».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «dimetiltriptamina (DMT)» and the row boundary the dossier records for that read is «uses the parent tryptamine entry without extending it to acetoxy or methoxy analogues.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «dmt schedule | dmt penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

DMT in Guyana, full detail →

DOM

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «DOM; stp», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The entry prints both the chemical abbreviation and the street synonym STP. Reading the two together is what stops the row being confused with medicines that share similar initials. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «DOM; stp» itself. The abbreviation on a wrapper is not evidence; the compound named in the entry has to be identified analytically. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «DOM; stp» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. There is no medicinal preparation of this compound, so the prescription question does not arise and an authorisation would be the only route. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: Nothing on a wrapper or a blotter sheet is documentation, and the STP synonym on a label does not identify the compound. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «DOM; stp».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «DOM · stp» and the row boundary the dossier records for that read is «checks the scheduled stp synonym and separates it from similarly abbreviated medicines.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «dom schedule | dom penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

DOM in Guyana, full detail →

Ephedrine

Legal status: Controlled as a precursor chemical, not as a narcotic. The Act prints «Ephedrine» at Fourth Schedule item 9, the list of precursor chemicals, and «Pseudo ephedrine» at item 21, and the Schedule extends to «The salts of the substances listed in this Schedule whenever the existence of such salts is possible». Section 15A makes it an offence (a) to manufacture or be in possession of a substance in that Schedule, or (b) to transport or supply it, «knowing or having reasonable grounds to suspect that the substance is to be used in or for the unlawful production of a narcotic»; as printed, those words follow limb (b), and the text does not settle whether they also govern limb (a). Section 2 defines a narcotic by reference to the First and Second Schedules only, and ephedrine is in neither, so it is not a narcotic or psychotropic substance under the Act. The dossier's string for this row, «efedrina», is a search term; the Act prints the English name. The version horizon: the lists read are the First to Fourth Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, as it stands at L.R.O. 1/2012, and section 15B lets the Minister add to or delete from the Fourth Schedule by order. The item numbers in this cell are read from the Act itself and are not printed in the quoted extract the dossier carries for this row, which is a search string.
Consequences if caught: Capital exposure: none. Ephedrine is not a narcotic under section 2, so neither the life ceiling in section 5(1) nor the capital provision in section 6(1) reaches it. A person convicted under section 15A is liable, on summary conviction, a fine of one hundred thousand dollars and imprisonment for five years, and on conviction on indictment a fine of two hundred thousand dollars and imprisonment for five years. No quantity threshold is printed, so the boundary between a pharmacy purchase and a diversion case is not drawn here.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is that ephedrine is a Fourth Schedule precursor and not a scheduled narcotic. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: Section 15C lets the Minister make regulations imposing requirements as to the documentation of transactions involving Fourth Schedule substances, and on records, labelling and transport. Whether any have been made was not searched, so no documentation rule is stated here, and none should be assumed absent. The First to Fourth Schedules were read for this row, and the Act prints «Ephedrine» at Fourth Schedule item 9.

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, sections 2, 15A, 15B and 15C, Fourth Schedule item 9 «Ephedrine», item 21 «Pseudo ephedrine» and the salts clause, as they stand at L.R.O. 1/2012, read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection, and measured in the cached text of that consolidation. The dossier's string «efedrina» is a search term. The citation is document level and not per substance. · Updated October 4, 2026

Ephedrine in Guyana, full detail →

Fentanyl

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «fentanilo», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The substance searched for is the parent opioid. The analogue family is not carried by it, and the dossier does not extend the result to carfentanil, to acetylfentanyl or to any other derivative. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «fentanilo» itself. A fentanyl analogue is reached, if at all, through the derivatives limb of group 4, «Phenylpiperidines, their preparations, derivatives and salts», which this row does not test. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «fentanilo» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Fentanyl patches and lozenges are dispensed for severe pain, which makes this one of the rows where the missing Guyanese import route has the most practical consequence. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: A patch carried loose in a wallet without its packaging is the worst version of this problem. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «fentanilo».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «fentanilo» and the row boundary the dossier records for that read is «checks the parent opioid without extending the result to every fentanyl analogue.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «fentanyl schedule | fentanyl penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Fentanyl in Guyana, full detail →

Heroin

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «heroína; diacetilmorfina», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The entry prints the common name and the chemical synonym together. The morphine entry is not substituted for it, which keeps the diamorphine question separate from the parent opiate. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band or tariff attached to «heroína; diacetilmorfina» itself. Section 5(2) prints a presumption: in a prosecution under section 5, a person found in possession of more than two grams of diacetylmorphine (heroin) bears the burden of proving a purpose other than trafficking. Identification as diacetylmorphine rather than as a morphine preparation is the fact in issue. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «heroína; diacetilmorfina» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Diamorphine is a licensed analgesic in a small number of countries, and the dossier records no Guyanese route for it. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: There is no ordinary traveller route for this substance, and a foreign diamorphine prescription is not a Guyanese authorisation. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «heroína; diacetilmorfina».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «heroína · diacetilmorfina» and the row boundary the dossier records for that read is «uses the diacetylmorphine synonym and does not substitute the morphine entry.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «heroin schedule | heroin penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Heroin in Guyana, full detail →

Hydrocodone

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «hidrocodona», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The entry is the named semisynthetic opioid, and any preparation exception is treated as a separate question rather than folded into the entry. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «hidrocodona» itself. A combination analgesic has to be tied to its hydrocodone content, and the dossier records no Guyanese threshold for combination products. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «hidrocodona» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Hydrocodone is dispensed as a combination analgesic in several countries, so the preparation question and the traveller question are the same question here, and neither is answered. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: Hydrocodone is almost never dispensed alone, so the document that matters is the one naming both actives, since the other active is usually paracetamol or ibuprofen and carries no schedule consequence at all. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «hidrocodona».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «hidrocodona» and the row boundary the dossier records for that read is «checks the named semisynthetic opioid and any preparation exception separately.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «hydrocodone schedule | hydrocodone penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Hydrocodone in Guyana, full detail →

LSD

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «lisergida (LSD)», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The substance searched for is lysergide. Newer lysergamides are not automatically included, and the 1P-LSD row in this corpus was checked separately and did not return a proved entry. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «lisergida (LSD)» itself. Blotter has to be analysed to the named compound, because a lysergamide analogue is not lysergide for this entry. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «lisergida (LSD)» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. LSD has no dispensed medicinal form, although it is in clinical trials in some countries, and no Guyanese authorisation route is recorded. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: No documentation route exists for blotter, and a vendor's dosage claim is not an analysis. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «lisergida (LSD)».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «lisergida (LSD)» and the row boundary the dossier records for that read is «uses the lysergide entry and does not automatically include newer lysergamides.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «lsd schedule | lsd penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

LSD in Guyana, full detail →

Mescaline

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «mescalina», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The substance searched for is the active phenethylamine. Peyote cactus material is handled on its own row in this corpus, so the constituent and the plant are kept apart even though the same entry name appears in both. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «mescalina» itself. Extracted material and cactus tissue raise different identification questions, and only the named constituent is placed by this entry. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «mescalina» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Mescaline is not dispensed as a medicine, and the dossier records no research, ceremonial or religious authorisation route in Guyana. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: No documentation reaches extracted mescaline, and a cactus grower's receipt speaks to the plant row rather than to this one. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «mescalina».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «mescalina» and the row boundary the dossier records for that read is «checks the active phenethylamine separately from peyote plant material.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «mescaline schedule | mescaline penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Mescaline in Guyana, full detail →

Methadone

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «metadona», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The entry is the synthetic opioid under its own name, and any preparation specific exception is preserved as a separate question rather than resolved here. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «metadona» itself. A dispensed liquid has to be tied to the printed entry, and the dossier records no Guyanese rule about takeaway doses. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «metadona» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Methadone is carried almost entirely as maintenance treatment, so a traveller on a programme faces the exact gap this dossier leaves: a placement that is settled and an import route that is not. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: A programme letter and a dispensing record are the documents that would be asked for, if Guyana has a route at all. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «metadona».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «metadona» and the row boundary the dossier records for that read is «uses the synthetic opioid entry and preserves any preparation-specific exception.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «methadone schedule | methadone penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Methadone in Guyana, full detail →

Methamphetamine

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «metanfetamina», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The substance searched for is the methylated stimulant. It is separated from amphetamine and from the mixed salt brand medicines that carry their own row here, so a result for one is not a result for the other. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «metanfetamina» itself. The laboratory distinction between amphetamine and its N-methyl homologue is what decides which row applies. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «metanfetamina» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Methamphetamine is prescribed in a small number of countries under a brand name, and the dossier records no Guyanese route for it. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: No ordinary traveller route exists, and a foreign prescription for the branded form is not a Guyanese authorisation. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «metanfetamina».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «metanfetamina» and the row boundary the dossier records for that read is «separates the methylated stimulant from amphetamine and its mixed-salt brands.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «methamphetamine schedule | methamphetamine penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Methamphetamine in Guyana, full detail →

Methaqualone (Quaaludes)

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «metacualona», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The entry is the quinazolinone sedative in its own right, which is how the row is settled rather than by grouping it with other hypnotics. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «metacualona» itself. Tablets have to be identified to the named compound, because the sedative effect is not the test. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «metacualona» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Methaqualone has been withdrawn as a medicine almost everywhere and no Guyanese authorisation is recorded. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: There is no current lawful supply to document anywhere, so a historical prescription would not help. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «metacualona».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «metacualona» and the row boundary the dossier records for that read is «checks the quinazolinone sedative as its own psychotropic entry.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «methaqualone schedule | methaqualone penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Methaqualone (Quaaludes) in Guyana, full detail →

Methylphenidate

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «metilfenidato», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The entry is the piperidine stimulant medicine under its own name, checked independently of amphetamine rather than grouped with it. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «metilfenidato» itself. The tablet's active ingredient is the fact in issue, and an attention deficit indication does not change which entry is reached. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «metilfenidato» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Methylphenidate is one of the most commonly carried prescribed stimulants and the dossier gives no Guyanese personal medicine route for it. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: A prescriber's letter naming methylphenidate and the daily dose is the document most likely to be needed. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «metilfenidato».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «metilfenidato» and the row boundary the dossier records for that read is «checks the piperidine stimulant medicine independently from amphetamine.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «methylphenidate schedule | methylphenidate penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Methylphenidate in Guyana, full detail →

Morphine

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «morfina», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The substance searched for is the parent opiate. Salts and preparations are checked only within the coverage the printed entry gives them, and the dossier does not record how far that coverage runs. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band or tariff attached to «morfina» itself. Section 5(2) prints a presumption: in a prosecution under section 5, a person found in possession of more than three grams of morphine bears the burden of proving a purpose other than trafficking. A preparation has to be tied to the entry, and whether a low concentration preparation falls outside it is not settled here. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «morfina» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Morphine is the standard strong analgesic and a patient carrying it is the ordinary case, which is why the missing import route is the operative fact rather than the placement. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: A palliative or post surgical prescription stating the dose and the duration is the document that matters. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «morfina».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «morfina» and the row boundary the dossier records for that read is «uses the parent opiate entry and checks salts and preparations only within printed coverage.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «morphine schedule | morphine penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Morphine in Guyana, full detail →

Nicotine

Legal status: Not assigned a controlled drug offence in Guyana. The scope search recorded for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «nicotina», and the dossier records the result as a scope finding: this substance is not placed in those Schedules and the Act's trafficking offence does not reach it. Nicotine sits with tobacco and nicotine product law, including vaping product rules, none of which this Act carries. That is a finding about this Act and about nothing else. Separate product, excise, tobacco, food and medicines law is expressly reserved, and the dossier does not describe it. The scope search was recorded on 20 September 2026.
Consequences if caught: Capital exposure: none for this row. The only capital provision in Guyana's Cap. 10:10, section 6(1), applies to supplying or administering a narcotic to a child or young person who dies as a result, and this row is not a narcotic under the Act, so the trafficking penalties of section 5(1), which reach imprisonment for life on indictment, do not apply to it either. This row does not reach even that, because no criminal controlled drug ceiling is assigned to it at all. Nicotine product rules are where the real restrictions live, and the dossier did not read them. The consequence is not that the substance is unregulated. It is that the regulation, whatever it amounts to, sits outside the criminal drug statute the dossier read, in law the dossier did not examine.
If prescribed / medical: Not a controlled drug question in Guyana, so there is no schedule placement for a prescription to be measured against. Nicotine replacement therapy is a licensed medicine in most countries and that licensing is part of the reserved law. The dossier carries no Guyanese prescription rule, import permit or personal allowance in any event, so nothing here should be read as a customs or duty allowance.
Documentation: Nicotine product paperwork, where any exists, comes from the vaping and tobacco regime and not from this Act. The scope finding recorded for this row was read on 20 September 2026 against «nicotina». Because the reserved law was never examined, the honest position is that this cell tells you what the drug statute does not do and not what any other statute does.

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, read for this row as a scope finding rather than a placement · the term searched is «nicotina» and the row boundary the dossier records for that search is «reserves tobacco and nicotine-product law outside the cited narcotics schedule.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «nicotine schedule | nicotine penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Nicotine in Guyana, full detail →

Opium

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «opio», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. Opium is what the entry names. Raw opium, prepared opium and the poppy plant itself are kept analytically separate, and the dossier does not record which of them the printed entry reaches. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band or tariff attached to «opio» itself. Section 5(2) prints a presumption: in a prosecution under section 5, a person found in possession of more than fifty-five grams of opium bears the burden of proving a purpose other than trafficking. Which form of the material is in issue may decide the case, and this dossier does not draw that line. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «opio» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Opium as such is not dispensed, although several of its alkaloids are, and those alkaloids carry their own rows in this corpus. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: There is no documentation route for raw or prepared opium, and a poppy product's culinary labelling does not answer the entry question. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «opio».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «opio» and the row boundary the dossier records for that read is «keeps raw opium, prepared opium and poppy plant provisions analytically separate.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «opium schedule | opium penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Opium in Guyana, full detail →

Oxycodone

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «oxicodona», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The entry is the named semisynthetic opioid, and any low dose preparation rule is treated separately rather than folded into the entry. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «oxicodona» itself. Oxycodone is the one opioid in this group whose diversion pressure comes chiefly from the modified release form, and the dossier records no Guyanese rule distinguishing the formulations from one another. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «oxicodona» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Oxycodone is dispensed after surgery in enormous volume, so a traveller carrying a part used pack part way through a course is the ordinary case, and the dossier settles the placement without settling the permission. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: A modified release tablet carries far more total drug than an immediate release one of the same nominal strength, so the formulation printed on the dispensing label is as much a part of this document as the number beside it. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «oxicodona».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «oxicodona» and the row boundary the dossier records for that read is «checks the named semisynthetic opioid and any low-dose preparation rule separately.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «oxycodone schedule | oxycodone penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Oxycodone in Guyana, full detail →

PCP

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «fenciclidina (PCP)», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The entry prints phencyclidine with its PCP synonym. It is not extended to the wider arylcyclohexylamine family, and the methoxetamine row in this corpus was checked separately and did not return a proved entry. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «fenciclidina (PCP)» itself. An arylcyclohexylamine has to be identified to phencyclidine specifically before this entry is reached. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «fenciclidina (PCP)» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Phencyclidine was withdrawn from human and veterinary use decades ago, so there is no current prescribing route anywhere. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: There is no lawful supply of phencyclidine to document, and its veterinary history is long closed. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «fenciclidina (PCP)».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «fenciclidina (PCP)» and the row boundary the dossier records for that read is «uses the phencyclidine synonym and does not extend it to every arylcyclohexylamine.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «pcp schedule | pcp penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

PCP in Guyana, full detail →

Peyote

Legal status: Controlled through its constituent, and the plant half of what the applied cell recorded has no support. That cell held «mescalina; lophophora williamsii» and said both appear in the entry. Read against the cached text of the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, as it stands at L.R.O. 1/2012, Lophophora returns 0, williamsii 0, peyote 0 and cactus 0. The Third Schedule, which is the Act's list of prohibited plants, names four and only four: «Cannabis», «Coca plant», «Papaver somniferum» and «Papaver setigerum». What places this row is the Second Schedule, Part I item 5, which prints «Mescaline» against 3, 4, 5-trimethoxy-phenethylamine, read with section 2, which defines a psychotropic substance as «any substance specified in the Second Schedule or anything that contains any substance specified in that Schedule». The cactus is reached because it contains that alkaloid and not because it is named, so what has to be shown in a given case is that the material contains mescaline. The version horizon, stated outright because an absence without one expires silently: the lists read are the First to Fourth Schedules to the Act as they stand at L.R.O. 1/2012, and section 102(1) lets the Minister add a substance to the First, Second or Third Schedule by order, so this does not rule out a later addition. The Part and item numbers in this cell are read from the Act itself and are not printed in the quoted extract the dossier carries for this row, which is a search string.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for the cactus or for mescaline. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing. Live or dried cactus and a purified extract are different evidential problems, because the plant is caught only as something that contains mescaline, so the presence of the alkaloid is what has to be shown.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: the cactus is a psychotropic substance under section 2 because it contains «Mescaline», which sits at Second Schedule Part I item 5 of Cap. 10:10, and that is what any authorisation would have to be granted against. Peyote is not dispensed as a medicine, and the dossier records no religious or ceremonial exemption in Guyana. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: Section 23 lets the Minister license the possession of a narcotic, and the dossier records no such licence, ceremonial exemption or traveller route for the cactus or its alkaloid. Peyote is not dispensed as a medicine, so there is no prescription to carry for it. The First to Fourth Schedules were read for this row; the dossier's string «mescalina; lophophora williamsii» is a search term, and the Act prints «Mescaline» at Second Schedule Part I item 5 and does not print the botanical name.

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, section 2, definition of psychotropic substance, Second Schedule Part I item 5 «Mescaline» and the Third Schedule, as they stand at L.R.O. 1/2012, with section 5(1) carrying the indictable trafficking ceiling · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection, and measured in the cached text of that consolidation. The dossier's string for this row, «mescalina · lophophora williamsii», is a search term: the Act prints «Mescaline» and does not print the botanical name. The citation is document level and not per substance. · Updated October 4, 2026

Peyote in Guyana, full detail →

Pink Cocaine / Tusi

Legal status: This is a label rather than a substance, and that is the confirmed answer and not an unresolved one. The dossier records «cocaína rosa; tusi; tucibi» against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 as a name that fixes no composition. Pink cocaine is a colour and a street name. Seized samples have been reported as ketamine, as MDMA, as caffeine mixtures and occasionally as a 2C compound, and the name predicts none of them. The consequence is definite: no entry can be applied until the constituent is identified, and a laboratory result rather than the name decides which row of this corpus governs. The label analysis was recorded on 20 September 2026.
Consequences if caught: Capital exposure: none. Guyana's Cap. 10:10 carries no death penalty at any tier; section 5(1) sets the indictable trafficking ceiling at life imprisonment, so the worst outcome this Act reaches is a life sentence. Which ceiling reaches a given seizure of this material cannot be answered from the label, because the dossier assigns it no single ceiling and requires the constituent, the authorisation and the conduct to be established first. The obvious trap is the word cocaine in the name, since samples sold under it frequently contain no cocaine at all. If the constituent proves to be a scheduled compound the life ceiling is in play; if it is not scheduled, no offence under this Act is made out. Neither branch is capital.
If prescribed / medical: Not a medicine question, because there is no single active ingredient for a prescription to name. It is not dispensed, not standardised and not a product with an active ingredient in the regulatory sense. The dossier carries no Guyanese prescription rule, import permit or personal allowance in any event.
Documentation: Nothing on the packaging of a street mixture is evidence of what is inside it. A certificate of analysis naming the actual constituents is the only document that means anything for this row, and it identifies the material rather than permitting it. The label record was read on 20 September 2026 against «cocaína rosa; tusi; tucibi».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, read for this row as a label analysis rather than a placement · the label recorded is «cocaína rosa · tusi · tucibi» and the row boundary the dossier records for it is «requires laboratory constituents because the colour and street name define no composition.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «pink-cocaine schedule | pink-cocaine penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated September 21, 2026

Pink Cocaine / Tusi in Guyana, full detail →

Poppers

Legal status: This is a label rather than a substance, and that is the confirmed answer and not an unresolved one. The dossier records «poppers; nitritos DE alquilo» against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 as a name that fixes no composition. Poppers is a commercial label covering several different alkyl nitrites. Amyl nitrite carries its own row in this corpus and did not return a proved entry, and that result does not answer for isobutyl, isopropyl or pentyl nitrite. The consequence is definite: no entry can be applied until the constituent is identified, and a laboratory result rather than the name decides which row of this corpus governs. The label analysis was recorded on 20 September 2026.
Consequences if caught: Capital exposure: none. Guyana's Cap. 10:10 carries no death penalty at any tier; section 5(1) sets the indictable trafficking ceiling at life imprisonment, so the worst outcome this Act reaches is a life sentence. Which ceiling reaches a given seizure of this material cannot be answered from the label, because the dossier assigns it no single ceiling and requires the constituent, the authorisation and the conduct to be established first. A bottle labelled as a room odouriser tells you nothing about which nitrite is inside, and the nitrites are marketed interchangeably. If the constituent proves to be a scheduled compound the life ceiling is in play; if it is not scheduled, no offence under this Act is made out. Neither branch is capital.
If prescribed / medical: Not a medicine question, because there is no single active ingredient for a prescription to name. Amyl nitrite has a historical clinical use as an antidote and in cardiology, but the retail product is not that. The dossier carries no Guyanese prescription rule, import permit or personal allowance in any event.
Documentation: The retail label is not a statement of contents for this purpose. A certificate of analysis naming the actual constituents is the only document that means anything for this row, and it identifies the material rather than permitting it. The label record was read on 20 September 2026 against «poppers; nitritos DE alquilo».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, read for this row as a label analysis rather than a placement · the label recorded is «poppers · nitritos DE alquilo» and the row boundary the dossier records for it is «requires the exact alkyl nitrite because the product label is chemically open ended.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «poppers schedule | poppers penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated September 21, 2026

Poppers in Guyana, full detail →

Psilocybin

Legal status: Controlled. The term the dossier records for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «psilocibina», which is the term the Act was searched under rather than an entry the Act prints, and the dossier records the row as verified on that basis rather than against a class label. The substance searched for is the phosphorylated tryptamine. Not every constituent of a psychoactive mushroom is carried by it, and psilocin in particular is a different compound that this dossier does not record as separately checked. Placement is all the schedule settles. Authorisation, purpose, preparation exceptions and the conduct charged all stay open, and this dossier resolves none of them. The entry was read on 20 September 2026.
Consequences if caught: Capital exposure: one narrow route. Section 6(1) of Guyana's Cap. 10:10 makes a person who unlawfully supplies or administers a narcotic to a child or young person who dies as a result «liable on conviction on indictment to suffer death as a felon», and section 2 counts a psychotropic substance in the Second Schedule as a narcotic. No per-substance figure is printed for this row, and there is no weight band, no tariff and no quantity threshold attached to «psilocibina» itself. Mushroom material has to be tied to a printed constituent, and either «psilocne, psilotsin» at Part I item 7 or «PSILOCYBINE» at item 8 places it. Section 5(1)(a) prints the band for any narcotic held for trafficking: on summary conviction a fine of not less than thirty thousand dollars or three times the market value, whichever is greater, together with imprisonment for not less than three years nor more than five years; on conviction on indictment a fine of not less than seventy-five thousand dollars or three times the market value, whichever is greater, together with imprisonment for life. Section 73(1)(b) provides that where imprisonment for life is required to be imposed, no lesser term may be given unless special reasons are recorded in writing.
If prescribed / medical: Deferred, and the deferral is the honest answer. The dossier carries no Guyanese prescription rule, no import permit route, no personal medicine allowance and no Ministry authorisation procedure at all, so there is no traveller rule here to state and none is invented. What is established is the placement: «psilocibina» sits in the First and Second Schedules to Cap. 10:10, which is what any authorisation would have to be granted against. Psilocybin is in clinical trials in several countries and the dossier records no Guyanese authorisation route. Settle the medical route with the Guyanese authorities before travelling rather than from this cell.
Documentation: A trial or treatment letter would not be a Guyanese authorisation, and mushroom material carries no document of any kind. Carry any controlled medicine in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient, the dose and the treatment period, because the schedule is read against the active ingredient and not against the product name. Nothing in the dossier confirms that Guyana accepts any of that, so treat it as the minimum a traveller can show and not as a permission. The First and Second Schedules were read for this row on 20 September 2026 and the entry the dossier recorded was «psilocibina».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, with section 5(1) carrying the indictable trafficking ceiling · the entry read for this row is «psilocibina» and the row boundary the dossier records for that read is «checks the phosphorylated tryptamine and not every psychoactive mushroom constituent.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «psilocybin schedule | psilocybin penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Psilocybin in Guyana, full detail →

Synthetic Cannabinoids (K2 / Spice)

Legal status: This is a label rather than a substance, and that is the confirmed answer and not an unresolved one. The dossier records «cannabinoides sintéticos» against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 as a name that fixes no composition. Synthetic cannabinoids are an open chemical class and not one molecule, and new compounds enter it continuously. Receptor activity is a pharmacological description and it does not define a schedule entry. The consequence is definite: no entry can be applied until the constituent is identified, and a laboratory result rather than the name decides which row of this corpus governs. The label analysis was recorded on 20 September 2026.
Consequences if caught: Capital exposure: none. Guyana's Cap. 10:10 carries no death penalty at any tier; section 5(1) sets the indictable trafficking ceiling at life imprisonment, so the worst outcome this Act reaches is a life sentence. Which ceiling reaches a given seizure of this material cannot be answered from the label, because the dossier assigns it no single ceiling and requires the constituent, the authorisation and the conduct to be established first. Sprayed plant material looks identical whichever compound is on it, and the compound is what any charge would have to name. If the constituent proves to be a scheduled compound the life ceiling is in play; if it is not scheduled, no offence under this Act is made out. Neither branch is capital.
If prescribed / medical: Not a medicine question, because there is no single active ingredient for a prescription to name. None of these compounds is a dispensed medicine, so no prescription route exists. The dossier carries no Guyanese prescription rule, import permit or personal allowance in any event.
Documentation: Herbal packaging naming a blend is not an ingredient list. A certificate of analysis naming the actual constituents is the only document that means anything for this row, and it identifies the material rather than permitting it. The label record was read on 20 September 2026 against «cannabinoides sintéticos».

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, read for this row as a label analysis rather than a placement · the label recorded is «cannabinoides sintéticos» and the row boundary the dossier records for it is «requires the exact molecule because receptor activity does not define one schedule entry.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «synthetic-cannabinoids schedule | synthetic-cannabinoids penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated September 21, 2026

Synthetic Cannabinoids (K2 / Spice) in Guyana, full detail →

Tobacco

Legal status: Not assigned a controlled drug offence in Guyana. The scope search recorded for this row against the First and Second Schedules to the Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10 is «tabaco», and the dossier records the result as a scope finding: this substance is not placed in those Schedules and the Act's trafficking offence does not reach it. Tobacco is regulated by its own statute, with duty, packaging, advertising and public place rules, and this cell reserves all of it. That is a finding about this Act and about nothing else. Separate product, excise, tobacco, food and medicines law is expressly reserved, and the dossier does not describe it. The scope search was recorded on 20 September 2026.
Consequences if caught: Capital exposure: none for this row. The only capital provision in Guyana's Cap. 10:10, section 6(1), applies to supplying or administering a narcotic to a child or young person who dies as a result, and this row is not a narcotic under the Act, so the trafficking penalties of section 5(1), which reach imprisonment for life on indictment, do not apply to it either. This row does not reach even that, because no criminal controlled drug ceiling is assigned to it at all. Customs allowances on tobacco are the practical constraint for a traveller and they are not in this Act. The consequence is not that the substance is unregulated. It is that the regulation, whatever it amounts to, sits outside the criminal drug statute the dossier read, in law the dossier did not examine.
If prescribed / medical: Not a controlled drug question in Guyana, so there is no schedule placement for a prescription to be measured against. Tobacco is not a prescribed medicine, so the prescription question does not arise. The dossier carries no Guyanese prescription rule, import permit or personal allowance in any event, so nothing here should be read as a customs or duty allowance.
Documentation: Customs declaration limits, not narcotics paperwork, are what apply. The scope finding recorded for this row was read on 20 September 2026 against «tabaco». Because the reserved law was never examined, the honest position is that this cell tells you what the drug statute does not do and not what any other statute does.

Narcotic Drugs and Psychotropic Substances (Control) Act, Cap. 10:10, First and Second Schedules, read for this row as a scope finding rather than a placement · the term searched is «tabaco» and the row boundary the dossier records for that search is «reserves the tobacco statute instead of assigning a controlled-drug trafficking penalty.» · read at https://mola.gov.gy/laws-of-guyana, the Ministry of Legal Affairs Laws of Guyana collection. The citation behind this cell is document level and not per substance. The source document carries exactly one hyperlink target for all 88 of its rows, and what it calls a links column holds constructed text such as «tobacco schedule | tobacco penalty» rather than a web address, so no page, paragraph or deep link exists for this row and none is invented here. Many of the dossier's entry and search strings are recorded in Spanish language or international nonproprietary form rather than in the English wording a Guyanese statute prints, so every string here is reproduced exactly as the dossier holds it and is not offered as the literal printed text of the Schedules · that discrepancy is recorded rather than resolved. Read as at 20 September 2026. · Updated October 4, 2026

Tobacco in Guyana, full detail →

Not individually verified

52 substances are not individually verified for Guyana

For these the governing national drug law is cited, but we have not verified that the substance specifically is scheduled under it. Treat them as unanswered, not as legal. Confirm with Guyana’s drug authority or your embassy.

Substance	What we found
1P-LSD	Not confirmed. No placement was established for 1P-LSD on this record, and the search that returned nothing is...
2-FDCK	Not confirmed. Not established on this record, and the search that returned nothing is the finding. The dossier...
25I-NBOMe	Not confirmed. Not established on this record, and the search that returned nothing is the finding. The dossier...
2C-B	Not confirmed. The applied cell recorded 2C-B as controlled on the term «2c-b», and said itself that this was the...
2C-E	Not confirmed. Not established on this record, and the search that returned nothing is the finding. The dossier...
2C-I	Not confirmed. Not established on this record, and the search that returned nothing is the finding. The dossier...
2C-T-7	Not confirmed. No placement was established for 2C-T-7 on this record, and the search that returned nothing is...
3-MMC	Not confirmed. Not established on this record, and the search that returned nothing is the finding. The dossier...
4-AcO-DMT	Not confirmed. No placement was established for 4-AcO-DMT on this record, and the search that returned nothing is...
4-HO-MET	Not confirmed. No placement was established for 4-HO-MET on this record, and the search that returned nothing is...
5-MeO-DMT (Bufo / Toad)	Not confirmed. No placement was established for 5-MeO-DMT on this record, and the search that returned nothing is...
6-APB	Not confirmed. No placement was established for 6-APB on this record, and the search that returned nothing is...
7-Hydroxymitragynine (7-OH)	Not confirmed. No placement was established for 7-hydroxymitragynine on this record, and the search that returned...
Amanita muscaria	Not confirmed. No placement was established for Amanita muscaria on this record, and the search that returned...
Amyl Nitrite	Not confirmed. No placement was established for amyl nitrite on this record, and the search that returned nothing is...
Benzodiazepines	Not confirmed. The applied cell says the dossier records an entry for five of the six members, naming alprazolam...
Cathinone	Not confirmed. The applied cell states this row as controlled, and the only string it offers for the placement is a...
CBD	Not confirmed. No placement was established for CBD on this record, and the search that returned nothing is recorded...
Clonazepam	Not confirmed. The applied cell recorded clonazepam as controlled on the term «clonazepam», and said itself that...
Diazepam	Not confirmed. The applied cell recorded diazepam as controlled on the term «diazepam», and said itself that this...
DXM	Not confirmed. Dextromethorphan is expressly outside the First Schedule. Group 11 of that Schedule brings in...
Etizolam	Not confirmed. No placement was established for etizolam on this record, and the search that returned nothing is...
Gabapentin	Not confirmed. No placement was established for gabapentin on this record, and the search that returned nothing is...
GBL	Not confirmed. Not established on this record, and the search that returned nothing is the finding. The dossier...
GHB	Not confirmed. The applied cell states this row as controlled, and the only string it offers for the placement is a...
HHC	Not confirmed. No placement was established for HHC on this record, and the search that returned nothing is recorded...
Ketamine	Not confirmed. The applied cell states this row as controlled, and the only string it offers for the placement is a...
Khat	Not confirmed. Not established on this record, and the search that returned nothing is the finding. The dossier...
Kratom	Not confirmed. No placement was established for kratom on this record, and the search that returned nothing is...
Lorazepam	Not confirmed. The applied cell recorded lorazepam as controlled on the term «lorazepam», and said itself that this...
LSA (Morning Glory)	Not confirmed. The applied cell recorded LSA as controlled on the term «ergometrina; ergina (LSA)», and said itself...
MDA	Not confirmed. The applied cell recorded MDA as controlled on the term «MDA», and said itself that this was the term...
MDMA	Not confirmed. The applied cell recorded MDMA as controlled on the term «MDMA», and said itself that this was the...
MDPV	Not confirmed. The applied cell recorded MDPV as controlled on the term «MDPV», and said itself that this was the...
Memantine	Not confirmed. No placement was established for memantine on this record, and the search that returned nothing is...
Mephedrone (4-MMC)	Not confirmed. The applied cell states this row as controlled, and the only string it offers for the placement is a...
Methylone	Not confirmed. The applied cell states this row as controlled, and the only string it offers for the placement is a...
Mitragynine	Not confirmed. No placement was established for mitragynine on this record, and the search that returned nothing is...
Modafinil	Not confirmed. No placement was established for modafinil on this record, and the search that returned nothing is...
MXE	Not confirmed. Not established on this record, and the search that returned nothing is the finding. The dossier...
Nimetazepam	Not confirmed. The applied cell recorded nimetazepam as controlled on the term «nimetazepam», and said itself that...
Nitrous Oxide	Not confirmed. No placement was established for nitrous oxide on this record, and the search that returned nothing...
Phenibut	Not confirmed. No placement was established for phenibut on this record, and the search that returned nothing is...
Pregabalin	Not confirmed. No placement was established for pregabalin on this record, and the search that returned nothing is...
Quetiapine	Not confirmed. No placement was established for quetiapine on this record, and the search that returned nothing is...
Salvia divinorum	Not confirmed. No placement was established for Salvia divinorum on this record, and the search that returned...
Scopolamine (Devil's Breath)	Not confirmed. The applied cell states this row as controlled, and the only string it offers for the placement is a...
THC-P	Not confirmed. No placement was established for THC-P on this record, and the search that returned nothing is...
Tramadol	Not confirmed. The applied cell recorded tramadol as controlled on the term «tramadol», and said itself that this...
Xanax (Alprazolam)	Not confirmed. The applied cell recorded alprazolam as controlled on the term «alprazolam», and said itself that...
Xylazine	Not confirmed. No placement was established for xylazine on this record, and the search that returned nothing is...
Zolpidem	Not confirmed. The applied cell recorded zolpidem as controlled on the term «zolpidem», and said itself that this...

Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.

Before you travel

Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.

If you’re detained or arrested abroad

Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →

← All countries Drug index